Adjustment RIAS A/S
Adjustment for RIAS A/S Attachment2023_09 Stock Exchange Announcement No. 9 Adjustment
Day: September 28, 2023
Grupo Bimbo Will Donate More Than 2.8 Million Slices of Bread to Help Those Who Need it Most
Written by Customer Service on . Posted in Public Companies.
Through the Bimbo Global Race, Grupo Bimbo committed to donating 20 slices of bread for each person registered.
This year, the Bimbo Global Race had 120 thousand people in the physical race globally and more than 300 thousand participants, including virtual runners.
The United States – where Bimbo Bakeries USA, part of Grupo Bimbo, is headquartered – was among the countries with the highest number of participants this year.HORSHAM, Pa., Sept. 28, 2023 (GLOBE NEWSWIRE) — Grupo Bimbo, the world’s leading bakery and parent company to Bimbo Bakeries USA, celebrated the 8th Bimbo Global Race, a social cause event to support active lifestyles and food donations to vulnerable communities. This year’s event had more than 300 thousand participants in 24 different cities from 17 countries worldwide. Thanks to the participation of hundreds...
Amicus Therapeutics Announces FDA Approval and Launch of New Treatment for Pompe Disease
Written by Customer Service on . Posted in Public Companies.
Pombiliti + Opfolda LogoPombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) Approved in ERT-Experienced Adults
First and Only Two-Component Therapy for Eligible Adults Living with Late-onset Pompe Disease
Amicus Therapeutics to Host Conference Call Today at 12:00 p.m. ET
PHILADELPHIA, Sept. 28, 2023 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that the U.S. Food and Drug Administration (FDA) has approved Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) 65mg capsules. This two-component therapy is indicated for adults living with late-onset Pompe disease (LOPD) weighing ≥40 kg and who are not improving on their current enzyme replacement therapy (ERT).
Late-onset Pompe disease is a rare, debilitating, and life-threatening lysosomal disorder caused...
Servus Credit Union continues its upward asset growth trajectory
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
EDMONTON, Alberta, Sept. 28, 2023 (GLOBE NEWSWIRE) — Servus Credit Union Ltd. (Servus) continued its growth trajectory in its third quarter of 2023, reaching $19.8 billion in assets – up $1.6 billion (9.2%) from the same period last year. This growth supports Servus’s continued strategic focus on and investment in enhanced member experience.
Year-to-date net interest income continued to trend positively with an increase of 7.6% over the prior year due to strong deposit and loan growth. While year-over-year operating expenses were higher due to continued investment in technology, products, services and growth-driving initiatives, operating expenses were reduced this quarter compared to the second quarter of 2023.
“Since 2022, we’ve been positioning Servus for the future by reimagining how Servus can best support...
Syneos Health Closes Transaction with Private Investment Firms
Written by Customer Service on . Posted in Mergers And Acquisitions.
Transaction Will Drive Ongoing Transformation and Accelerate Delivery of Tech-Enabled, Fit-for-Purpose Solutions to Biopharma Customers
MORRISVILLE, N.C., Sept. 28, 2023 (GLOBE NEWSWIRE) — Syneos Health, Inc. (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organization, today announced the completion of its acquisition by a consortium of private investment firm affiliates composed of Elliott Investment Management L.P., Patient Square Capital and Veritas Capital.
As a result of the transaction, Syneos Health is now a privately held company. With the support of its new private investors, the Company will be poised to further accelerate its transformation, fuel investments in technology that better differentiate its integrated solutions and expand its commitment to better serve customers.
Under...
WISe.ART The Future of Philanthropy: NFTs and Empowerment Through Art
Written by Customer Service on . Posted in Public Companies.
WISe.ART The Future of Philanthropy: NFTs and Empowerment Through Art
GENEVA – September 28, 2023: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a global leader in cybersecurity, digital identity, and Internet of Things (IoT) solutions operating as a holding company, announced today that its WISe.ART Corp subsidiary it will donate the proceeds from the sale of 200 NFTs to support the Swiss Red Cross. The Red Cross Ball in Geneva, a charity event organized by the Swiss Red Cross and the Geneva Red Cross will raise funds for humanitarian projects and programmes that support disadvantaged sectors of the world’s population. This year, the Swiss Red Cross Ball will take place Saturday, September 30, 2023 at the Campus HEAD in Geneva.
In an increasingly digitalized world, the intersection of art and technology...
Unaudited Half-Yearly Financial Report
Written by Customer Service on . Posted in Public Companies.
FORESIGHT ENTERPRISE VCT PLCLEI: 213800MWJNR3WZZ3ZP42
UNAUDITED HALF-YEARLY FINANCIAL REPORTFOR THE PERIOD ENDED 30 JUNE 2023
Financial HighlightsTotal net assets £148.2 million
An interim dividend of 3.3p per share was paid on 30 June 2023, returning £7.7 million to Shareholders
The portfolio value has increased by £3.2 million in the last six months
Net Asset Value per share decreased by 2.3% in the period from 64.9p at 31 December 2022 to 63.4p at 30 June 2023
Including the payment of a 3.3p dividend made on 30 June 2023, NAV Total Return per share at 30 June 2023 was 66.7p (being NAV at the end of the period plus dividends paid in the period), representing a positive NAV Total Return of 2.8% in the periodChair’s Statement
I am pleased to present the unaudited Half-Yearly Report for Foresight Enterprise VCT plc for the period ended...
Global Fermentation Chemicals Market Size to Reach USD 136.74 Billion in 2032 | Emergen Research
Written by Customer Service on . Posted in Mergers And Acquisitions.
Increasing focus on bioavailability enhancement is a major factor driving the fermentation chemicals market revenue growth
Vancouver, Sept. 28, 2023 (GLOBE NEWSWIRE) — The global fermentation chemicals market size was USD 71.16 Billion in 2022 and is expected to register a revenue CAGR of 6.7% during the forecast period, according to the latest analysis by Emergen Research. The global shift toward a bio-based economy and rising environmental concerns are major factors driving the market revenue growth. End-use companies are rapidly shifting from petrochemical-based products to bio-based alternatives produced through fermentation. In addition, consumers in various countries are becoming conscious of the environmental and health impacts of petrochemical-based products.
This awareness is creating a high demand for bio-based and eco-friendly...
Velocity Continues Strategic Expansion of its MGA Platform Acquiring Majority Stake in Insight Risk Technologies
Written by Customer Service on . Posted in Mergers And Acquisitions.
Nashville, TN, Sept. 28, 2023 (GLOBE NEWSWIRE) — Velocity HoldCo, LLC (“Velocity”), the holding company for Velocity Risk Underwriters, LLC, Velocity Specialty Insurance Company, and Velocity Claims LLC, and Insight Risk Technologies LLC (“Insight Risk”) together announce Velocity’s acquisition of a majority stake in Insight Risk, a leading one-stop loss prevention and risk transfer solution provider for the Builder’s Risk market. The acquisition, which closed on September 18th, continues Velocity’s strategic expansion and represents their second successful acquisition and first Managing General Agent (“MGA”) acquisition. It also represents a significant advancement for Insight Risk as they work towards expanding their market presence.
“This marks another exciting milestone in fortifying our position as...
Kineta Announces Participation at October Investor Conferences
Written by Customer Service on . Posted in Public Companies.
SEATTLE, Sept. 28, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today its participation in the following upcoming investor conferences in October 2023.
JonesTrading 2023 Healthcare Summit Format: Investor meetingsLocation: Miami, FLDate: October 9-11, 2023
BIO Investor ForumFormat: Corporate presentation and investor meetingsLocation: San Francisco, CADate: Tuesday, October 17, 2023Time: 1:15-2:00 P.M. Pacific Time
OPAL Group Family Office & Private Wealth Management Forum West 2023Format: Corporate presentation and investor meetingsLocation: Napa, CADate: Thursday, October 19, 2023Time: 10:50-11:10 P.M. Pacific Time
About KinetaKineta (Nasdaq: KA) is a clinical-stage...
